UNSPSC 41202006: Blastomyces dermatitidisserological reagents

In this classification, Blastomyces dermatitidis serological reagents are devices used in test to identify specific Blastomyces dermatitidis antibodies in serum. US FDA regulates Blastomyces dermatitidis serological reagents under 21 CFR 866.3060 and under FDA product code LSH.

UNSPSC 41202006 Blastomyces dermatitidis serological reagents is a Commodity code that in recent state and local procurement shows little activity directly aligned with the code's nominal scope. The recent opportunities posted under this code instead reflect demand for HIV, Syphilis, and Hepatitis B and C testing reagents, screening assays, and related diagnostic laboratory services—a significant scope mismatch with the code's stated focus on Blastomyces dermatitidis (a fungal pathogen) serological testing. State and local health departments, criminal justice agencies, and higher-education institutions are the primary issuing bodies, with the Illinois Department of Public Health (IDPH) appearing multiple times in recent solicitations. The work actually being solicited includes blood chemistry reagents, nonautomated diagnostic testing, automated multi-analyte screening instruments with laboratory information system integration, rapid HIV and Syphilis test kits for public health programs, offender drug testing services with immunoassay screening and confirmatory testing (LC/MS/MS or GC/MS), and forensic serological analysis with expert witness testimony.

Geographic activity concentrates in Texas, Illinois, and Florida, with secondary activity in Arizona (University of Houston solicitation). Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (response due July 23, 2026, estimated contract value $600,000 annually for approximately 25,031 tests), the City of Austin's IFB 9100AAM1023 for Abbott Determine HIV 1/2 Ag/Ab Combo test kits (response due July 17, 2026), the Illinois Department of Public Health's IFB 26482DPHOFCDIB50489 for Hepatitis/HIV/Syphilis 4th generation screening assays and instrumentation (response due March 16, 2026, five-year term with five additional renewal years), and the Texas Department of Criminal Justice's RFP 696-IG-26-P034 for forensic analysis services including serology and DNA testing (response due May 13, 2026, one-year base period with four optional one-year renewals). The code shows persistent activity in public health and criminal justice testing services, though the disconnect between the code's nominal scope and actual procurements warrants verification with issuing bodies before pursuing.